Translations:Diabetes medication/30/ja: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
Created page with "第二世代スルホニル尿素薬の典型的な糖化ヘモグロビン (A1C)値の減少は1.0-2.0％である。 * 第一世代の薬剤 ** tolbutamide/ja ** acetohexamide/ja ** tolazamide/ja ** chlorpropamide/ja * 第二世代の薬剤 ** glipizide/ja ** グリブリド、あるいはglibenclamidex/ja ** glimepiride/ja ** gliclazide/ja ** glyclopyramide/ja ** gliquidone/ja"
 
(No difference)

Latest revision as of 18:05, 4 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Diabetes medication)
Typical reductions in [[glycated hemoglobin]] (A1C) values for second-generation sulfonylureas are 1.0–2.0%.
* First-generation agents
** [[tolbutamide]]
** [[acetohexamide]]
** [[tolazamide]]
** [[chlorpropamide]]
* Second-generation agents
** [[glipizide]]
** glyburide or [[glibenclamide]]
** [[glimepiride]]
** [[gliclazide]]
** [[glyclopyramide]]
** [[gliquidone]]

第二世代スルホニル尿素薬の典型的な糖化ヘモグロビン (A1C)値の減少は1.0-2.0％である。

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Diabetes_medication/30/ja&oldid=110698"